Leonteq Securities’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$175K Sell
2,025
-1,955
-49% -$163K 0.01% 539
2026
Q2
$268K Sell
3,980
-11,594
-74% -$772K 0.01% 511
2026
Q1
$978K Sell
15,574
-16,391
-51% -$1.14M 0.04% 294
2025
Q4
$2.12M Sell
31,965
-14,631
-31% -$946K 0.06% 213
2025
Q3
$3.14M Buy
46,596
+27,885
+149% +$2.21M 0.1% 149
2025
Q2
$1.63M Sell
18,711
-109,181
-85% -$8.56M 0.06% 187
2025
Q1
$8.62M Buy
127,892
+72,478
+131% +$5.91M 0.48% 32
2024
Q4
$4.31M Sell
55,414
-4,013
-7% -$297K 0.29% 84
2024
Q3
$3.98M Buy
59,427
+47,689
+406% +$3.92M 0.3% 76
2024
Q2
$1.33M Buy
11,738
+6,113
+109% +$773K 0.09% 176
2024
Q1
$780K Sell
5,625
-7,053
-56% -$887K 0.06% 253
2023
Q4
$1.57M Sell
12,678
-30,191
-70% -$3.08M 0.09% 196
2023
Q3
$4M Buy
42,869
+33,379
+352% +$3.76M 0.22% 102
2023
Q2
$1.22M Buy
9,490
+1,175
+14% +$142K 0.06% 247
2023
Q1
$966K Sell
8,315
-3,542
-30% -$396K 0.04% 277
2022
Q4
$1.34M Sell
11,857
-4,242
-26% -$466K 0.05% 253
2022
Q3
$1.3M Sell
16,099
-34,710
-68% -$2.94M 0.05% 246
2022
Q2
$3.79M Buy
50,809
+35,465
+231% +$3.24M 0.14% 133
2022
Q1
$1.96M Buy
15,344
+1,104
+8% +$121K 0.07% 204
2021
Q4
$1.91M Buy
14,240
+3,516
+33% +$505K 0.07% 231
2021
Q3
$1.47M Sell
10,724
-6,684
-38% -$843K 0.06% 243
2021
Q2
$1.86M Sell
17,408
-12,760
-42% -$1.23M 0.11% 170
2021
Q1
$2.71M Buy
30,168
+2,988
+11% +$280K 0.16% 122
2020
Q4
$2.51M Buy
+27,180
New +$2.43M 0.13% 138

Other funds holding DXCM

Leonteq Securities's DXCM Position: Q3 2026 in Review

Leonteq Securities reduced its DexCom (DXCM) stake by 49% in Q3 2026, selling an estimated $163K and leaving 2,025 shares worth $175K. The position accounts for 0.01% of the portfolio, ranked #539.

Leonteq Securities first reported a position in DXCM in Q4 2020 and has held it in 24 quarters since. The position peaked at $8.62M in Q1 2025. 1,028 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Leonteq Securities held 2,025 shares of DexCom worth $175K as of Q3 2026.
  • Leonteq Securities sold 1,955 DexCom shares in Q3 2026, an estimated $163K.
  • DexCom made up 0.01% of Leonteq Securities's portfolio in Q3 2026, its #539 holding.
  • Leonteq Securities first reported a position in DexCom in Q4 2020 and has held it in 24 quarters since.
  • Leonteq Securities's DexCom position peaked at $8.62M in Q1 2025.
  • 1,028 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.